ADAMTS13 and thrombotic thrombocytopenic purpura: Published results were not available for two studies: the ConNeCT Study (Neurological Complications of TTP), an observational study, and CAPLAVIE (Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult TTP), a clinical trial [26,27].